11-01-2019 | Oncology | News | Article
Taking proton pump inhibitors alongside tyrosine kinase inhibitors is associated with an increased mortality risk in older cancer patients, research indicates.
03-12-2018 | Chronic myeloid leukaemia | Video
Presenting author Fausto Castagnetti discusses the results of their study assessing the best score to predict outcomes in older patients with chronic myeloid leukaemia (4:17).
09-04-2018 | Leukaemia | News | Article
Click through for more information about these leukemia decisions
07-03-2018 | Oncology | News | Article
The tyrosine kinase inhibitor dasatinib is effective and well tolerated as a first- or second-line therapy for children with chronic myeloid leukemia in the chronic phase, research confirms.
05-01-2018 | Oncology | News | Article
Read more on this US FDA decision here
21-12-2017 | Oncology | News | Article
Read more on these decisions here